Is CyberArk The Next Big Cybersecurity Stock?
CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…
Buy
62
CL Quote, Financials, Valuation and Earnings
Last price:
$89.49
Seasonality move
:
4.72%
Day range:
$89.75 - $91.37
52-week range:
$85.32 - $109.30
Dividend yield:
2.21%
P/E ratio:
25.77x
P/S ratio:
3.71x
P/B ratio:
347.24x
Volume:
5.6M
Avg. volume:
5.1M
1-year change:
2.56%
Market cap:
$73.6B
Revenue:
$20.1B
EPS (TTM):
$3.52
Colgate-Palmolive Number of Institutional Trades
Colgate-Palmolive Volume of Institutional Trades
Amount of Institutions Buying
--
(Last Month)
Amount of Institutional Buying
$35.9B
(Last 6 Months)
Current Institutional Ownership Percentage
--
Amount of Institutions Selling
--
(Last Month)
Amount of Institutional Selling
$64.7B
(Last 6 Months)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Colgate-Palmolive Institutional Ownership
-
What Percentage Of CL Is Owned by Institutions?
-- of CL is owned by institutions.
-
How Many Institutions Own CL Shares?
Colgate-Palmolive stock is owned by 3,131 institutional shareholders at this time.
-
Have Institutions Been Buying CL Stock?
Yes, institutions have bought 225.9M shares of CL in the last quarter.
-
Have Institutions Been Selling CL Stock?
Yes, institutions have sold 345M shares of CL over the last quarter.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is the Market Going to Go Lower?
The last month has been extremely difficult for the stock…
2 Dividend Stocks to Buy in a Recession
While many economists and investors initially expected 2025 to be…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
54
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 41x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Alerts
Buy
52
RGC alert for Mar 18
Regencell Bioscience Holdings [RGC] is up 73.51% over the past day.
Buy
63
EXOD alert for Mar 18
Exodus Movement [EXOD] is down 3.96% over the past day.
Sell
45
MNPR alert for Mar 18
Monopar Therapeutics [MNPR] is up 0.93% over the past day.
